Cite
MLA Citation
J. Hillson et al.. “FRI0182 A Single Dose Study Comparing Pharmacokinetics, Safety, and Immunogenicity of M923 (A Proposed Biosimilar To Adalimumab), US-Sourced Adalimumab, and EU-Sourced Adalimumab in Healthy Subjects.” Annals of the rheumatic diseases, vol. 75, n.d., pp. 495–496. http://access.bl.uk/ark:/81055/vdc_100135155788.0x000056